These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30848981)
1. Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf. Vieira IL; Tamura RE; Hunger A; Strauss BE J Interferon Cytokine Res; 2019 Apr; 39(4):246-258. PubMed ID: 30848981 [TBL] [Abstract][Full Text] [Related]
2. Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo. Merkel CA; Medrano RF; Barauna VG; Strauss BE Cancer Gene Ther; 2013 May; 20(5):317-25. PubMed ID: 23618951 [TBL] [Abstract][Full Text] [Related]
3. p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro. Da-Costa RC; Vieira IL; Hunger A; Tamura RE; Strauss BE Braz J Med Biol Res; 2020; 53(3):e8876. PubMed ID: 32077463 [TBL] [Abstract][Full Text] [Related]
4. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6. Merkel CA; da Silva Soares RB; de Carvalho AC; Zanatta DB; Bajgelman MC; Fratini P; Costanzi-Strauss E; Strauss BE BMC Cancer; 2010 Jun; 10():316. PubMed ID: 20569441 [TBL] [Abstract][Full Text] [Related]
5. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy. Medrano RF; Catani JP; Ribeiro AH; Tomaz SL; Merkel CA; Costanzi-Strauss E; Strauss BE Cancer Immunol Immunother; 2016 Apr; 65(4):371-82. PubMed ID: 26887933 [TBL] [Abstract][Full Text] [Related]
6. Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation. Cerqueira OLD; Clavijo-Salomon MA; Cardoso EC; Citrangulo Tortelli Junior T; Mendonça SA; Barbuto JAM; Strauss BE Front Immunol; 2020; 11():576658. PubMed ID: 33193370 [TBL] [Abstract][Full Text] [Related]
7. The Cdkn2a gene product p19 alternative reading frame (p19ARF) is a critical regulator of IFNβ-mediated Lyme arthritis. Li J; Ma Y; Paquette JK; Richards AC; Mulvey MA; Zachary JF; Teuscher C; Weis JJ PLoS Pathog; 2022 Mar; 18(3):e1010365. PubMed ID: 35324997 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of subcutaneous mouse melanoma and induction of natural killer cells by liposome-mediated interferon-beta gene therapy. Ryuke Y; Mizuno M; Natsume A; Suzuki O; Nobayashi M; Kageshita T; Matsumoto K; Saida T; Yoshida J Melanoma Res; 2003 Aug; 13(4):349-56. PubMed ID: 12883360 [TBL] [Abstract][Full Text] [Related]
10. Expression of a metastatic phenotype in IFNs-primed/TNFalpha-activated B16 murine melanoma cells: role of JAK1/PKCdelta signal transduction factors. Bianchini F; Mannini A; Mugnai G; Ruggieri S; Calorini L Clin Exp Metastasis; 2006; 23(3-4):203-8. PubMed ID: 17028922 [TBL] [Abstract][Full Text] [Related]
11. Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy. Hunger A; Medrano RF; Strauss BE Cell Death Dis; 2017 May; 8(5):e2784. PubMed ID: 28492558 [No Abstract] [Full Text] [Related]
18. Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer. Strauss BE; Silva GRO; de Luna Vieira I; Cerqueira OLD; Del Valle PR; Medrano RFV; Mendonça SA Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e479s. PubMed ID: 30208166 [TBL] [Abstract][Full Text] [Related]
19. T-cell receptor gene therapy of established tumors in a murine melanoma model. Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006 [TBL] [Abstract][Full Text] [Related]
20. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Catani JPP; Medrano RFV; Hunger A; Del Valle P; Adjemian S; Zanatta DB; Kroemer G; Costanzi-Strauss E; Strauss BE Transl Oncol; 2016 Dec; 9(6):565-574. PubMed ID: 27916291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]